The Yale Center for the Science of Cannabis and Cannabinoids recently released their list of inaugural Pilot Award winners.
Image | adobe.stock/Thanakrit
A recent press release announced the Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN²) revealed their Pilot Award winners (1). The award program provides over $600,000 worth of grants to 14 researchers from the Yale School of Medicine. With these funds, researchers will be able to use them on a variety of projects that will study the effects cannabis and cannabinoids have on mental health and neurodevelopment. Once the research studies gather and review the data, the information is then made available so that the public, scientific community, and healthcare professionals are able to be educated on the data findings.
In 2023, YC-SCAN² was founded and aimed to provide a space for cannabis research and related studies such as, cannabinoids (1,2). Deepak Cyril D’Souza, MD, Vikram Sodhi ’92 Professor of Psychiatry, directs and manages the program.
“We received a highly competitive set of applications making for a challenging selection process,” D’Souza explained (1). We are grateful to our reviewers who brought their expertise in basic and clinical sciences in reviewing these applications.” He added that (1), “The projects cover a broad range of topics from the effects of cannabinoids on fetal neurodevelopment and adolescent brain development, the therapeutic potential of beta-caryophyllene for pain, to the impact of cannabis in schizophrenia,” he said. “The projects are led by investigators at different stages of their careers utilizing several novel approaches. We are optimistic that these projects will advance the science of cannabis and cannabinoids and bring Yale closer to the forefront of cutting-edge research in the area.”
As mentioned in the press release, funding for the grants was provided by Yale University. Here is a list of the recipients are (1):
References
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.